comparemela.com

Latest Breaking News On - John torous - Page 2 : comparemela.com

First Prescription App for Depression Gets FDA Approval

The FDA's approval of Rejoyn, a prescription app designed to assist in treating major depression, marks a significant milestone in digital mental health care.

United statesLeila fadelJohn torousDrug administrationBeth israel deaconess medical center

FDA Approves First Prescription App for Depression

The US Food and Drug Administration has approved the first-ever prescription app for major depressive disorder.

David benshoof kleinJohn torousDrug administrationHarvard medical schoolOtsuka pharmaceuticalClick therapeuticsDigital psychiatry divisionBeth israel deaconess medical centerMedscape medicalMontgomery asberg depression rating scaleMedscape medical newsMajor depressionMajor depressive disorderNipolar depressionClinical depressionAntidepressant drug

When mental health apps make false claims and cause unintended harm to users

Demand for mental health apps has soared in recent years but many fail to meet the quality threshold for issues such as clinical effectiveness, data privacy and security

United statesUnited kingdomJohn torousDavid murphyCamille nadalFiona coyleHealth products regulatory authorityTrinity college dublinHealth appsHarvard medical schoolUs federal trade commissionUnited organisation for the review of careMental health reformYour mental health info lineGoogle playData protection commission

Rejoyn Therapy App for Depression Approved by the FDA

The Rejoyn therapy app was approved by the FDA as add-on treatment for adults with depression who are already taking an antidepressant.

Beth israel medical centerNew yorkUnited statesJohn torousOtsuka americaBrian iacovielloJohn krausDavid benshoof kleinDrug administrationIcahn school of medicine at mount sinaiBeth israel deaconess medical centerAmerican psychiatric associationClick therapeuticsSmartphone app can makeEmotional faces memory taskIcahn school

FDA clears first digital treatment for depression, but experts caution that research is still early

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.

United statesJohn krausJohn torousBrian iacovielloDrug administrationOtsuka pharmaceuticalClick therapeuticsEmotional faces memory taskDigital psychiatryBeth israel deaconess medical center

vimarsana © 2020. All Rights Reserved.